On Sep 28, 2021 Kytopen closed a Series A round and raised $30,000,000 from Alexandria Venture Investments, Horizon Ventures, John Ballantyne, MassVentures, Michael Chambers, Northpond […]
Post-IPO Equity – Oxford BioMedica
On Sep 22, 2021 Oxford BioMedica closed a Post-IPO Equity round and raised £50,000,000 from Serum Institute of India Pvt. Ltd., featuring lead investors Serum […]
Series B – 54gene
On Sep 16, 2021 54gene closed a Series B round and raised $25,000,000 from Adjuvant Capital, Cathay Innovation, Endeavor Catalyst, Ingressive Capital, KdT Ventures, Plexo […]
Series B – 54gene
On Sep 16, 2021 54gene closed a Series B round and raised $25,000,000 from Adjuvant Capital, Cathay Innovation, Endeavor Catalyst, Ingressive Capital, KdT Ventures, Plexo […]
Series A – iECURE
On Sep 9, 2021 iECURE closed a Series A round and raised $50,000,000 from OrbiMed, Versant Ventures, featuring lead investors OrbiMed, Versant Ventures. About the […]
Series D – Mammoth Biosciences
On Sep 9, 2021 Mammoth Biosciences closed a Series D round and raised $150,000,000 from Decheng Capital, Foresite Capital, Greenspring Associates, Mayfield Fund, NFX, Plum […]
Post-IPO Equity – Bluebird Bio
On Sep 8, 2021 Bluebird Bio closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors . About the company: Bluebird Bio […]
Circulomics acquired by Pacific Biosciences
Aug 3, 2021 Pacific Biosciences has entered into an agreement to acquire Circulomics . Pacific Biosciences based at Menlo Park, California, United States. “PacBio highly […]
Circulomics acquired by Pacific Biosciences
Aug 3, 2021 Pacific Biosciences has entered into an agreement to acquire Circulomics . Pacific Biosciences based at Menlo Park, California, United States. “PacBio highly […]
Series A – Protera
On Jul 29, 2021 Protera closed a Series A round and raised $10,000,000 from Grupo Bimbo, ICL Group, Sofinnova Partners, featuring lead investors Sofinnova Partners. […]
